Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NOVAVAX, INC.

(NVAX)
  Rapport
Temps Différé Nasdaq  -  22:00:00 01/02/2023
11.23 USD   +2.93%
18/01Novavax déclare que son partenaire sud-coréen a obtenu l'autorisation d'utiliser le vaccin COVID-19 comme rappel pour adultes
MT
18/01Novavax COVID-19 Jab reçoit l'aval de la Corée du Sud en tant que rappel pour les adultes
MT
18/01Novavax : approbation du vaccin Covid comme rappel en Corée
CF
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur NOVAVAX, INC.
27/01FDA advisers back the same COVID vaccine for initial shots, boosters
26/01Novavax busca un período de 6 meses para producir vacunas COVID que coincidan con las n..
26/01Novavax needs 6 months to produce annual COVID shots that match new variants
25/01Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
20/01River Private Wealth announces new round of investment in Novavax, Inc
20/01Novavax, Inc. announced that it has received $6.75 million in funding from River Privat..
18/01Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult..
18/01Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults
18/01Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
13/01ANALYSEN DES TAGES von Dow Jones Newswires (13.01.2023)
10/01Presse Rundblick - Dienstag, 10. Januar
10/014 minutos de mercados del martes 10 de enero
10/01Cronache di Borsa - Martedì 10 gennaio
10/01MarketScreener's World Press Review: January 10
10/01North American Morning Briefing: More Hawkish Fed -2-
09/01Novavax's longtime CEO Stanley Erck to retire
09/01Novavax Appoints John Jacobs as CEO
09/01Novavax's longtime CEO Stanley Erck to retire
09/01Novavax Inc : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi..
09/01Novavax Names John C. Jacobs as New President & Chief Executive Officer
09/01Novavax, Inc. Announces Management Changes
09/01Novavax, Inc. Announces Chief Executive Officer Changes
09/01Novavax CEO Stanley Erck to retire
09/01Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
2022Novavax Initiates Phase 2 Trial for COVID-19-Influenza Combination, Stand-Alone Influen..
2022Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and St..
2022Novavax, Inc. Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination ..
2022Novavax Completes Offerings of Common Shares, Convertible Notes for Gross Proceeds of $..
2022Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
2022Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2..
2022Dow Jones Industrial : Todo en short: los vendedores en corto ganar..
2022Analysis-Short sellers gain nearly $304 billion after tumble in U.S. stocks
2022Novavax to Start Influenza's Phase 2 CIC Trial by 2022 End
2022Novavax Inc : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
2022Novavax Inc : Entry into a Material Definitive Agreement, Other Events, Financial Statemen..
2022German Health Authority Expands Recommendation for Use of Novavax COVID-19 Vaccine as a..
2022Novavax Receives Expanded Recommendation For COVID-19 Vaccine From Germany
2022Sector Update: Health Care Stocks Stumble on Friday
2022Sector Update: Health Care Stocks Lose Ground in Friday Trading
2022Sector Update: Health Care
2022Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Offi..
2022Sector Update: Health Care Stocks Mixed Premarket Friday
2022Weak Retail Spending, Recession Fears Expected to Continue Weighing on US Equities
2022Sector Update: Health Care
2022Novavax Prices $150 Million Senior Notes Offering, $65 Million Common Stock Offering
2022MORNING BRIEFING - USA/Asien
2022MORNING BRIEFING - Deutschland/Europa
2022Novavax Announces Pricing of $65 Million Public Offering of Common Stock
2022Novavax Announces Pricing of $65 Million Public Offering of Common Stock
2022Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes
2022Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes
2022Novavax's Shares Drop 37% After Cut In COVID-19 Vaccine Supplies To UK
2022Aktien New York Schluss: Heftige Verluste - Frust wegen Fed hält..
2022Nordson, AbCellera rise; Warner Bros., Novavax fall
2022MÄRKTE USA/Zins- und Rezessionsängste schicken Aktien auf Talfahrt
2022Aktien New York: Indizes weiten heftige Verluste wegen US-Geldpolitik no..
2022Top Midday Decliners
2022Novavax Down 26% After Announcing Stock and Convertible Note Sales
2022MÄRKTE USA/Zinsängste schicken Aktien auf Talfahrt
2022Aktien New York Eröffnung: Weitere klare Verluste wegen US-Gel..
2022Global markets live: HSBC, Tesla, Microsoft, Blackstone, Serco...
2022MÄRKTE USA/Weiter abwärts nach Fed-Aussagen
2022No Christmas rally this year?
2022Sector Update: Health Care Stocks Mixed Premarket Thursday
2022MÄRKTE USA/Weiter abwärts nach Fed-Aussagen - Tesla schwach erwartet
2022Aktien New York Ausblick: Weitere Verluste - Enttäuschung über ..
2022North American Morning Briefing: Rough Start For Futures..
2022MARKT USA/Weiter abwärts nach Fed-Aussagen - Tesla schwach erwartet
2022Novavax Inc : Regulation FD Disclosure, Other Events (form 8-K)
2022Novavax, Inc. Reaffirms Revenue Guidance for the Full Year 2022
2022Novavax Plans $125 Million Common-Stock Offering, $125 Million Debt Offering; Shares De..
2022Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes
2022Novavax Announces Proposed $125 Million Public Offering of Common Stock
2022Novavax Secures Expanded Use for COVID-19 Booster in Switzerland, France
2022Novavax : Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid ..
2022NOVAVAX INC Change in Directors or Principal Officers (form 8-K/A)
2022Novavax, Inc. Appoints Richard J. Rodgers as Member of Its Audit Committee and as A Mem..
2022French Public Health Body Snubs Valneva in COVID-19 Vaccine Strategy
2022Valneva shares fall as French health body advises against its COVID-19 vaccine
2022Novavax's COVID-19 Jab Gets Canadian Approval for Adolescents
2022Novavax Covid-19 Vaccine Gets Health Canada Approval for Adolescents
2022Novavax Says Canadian Regulator Approves Nuvaxovid COVID-19 Vaccine for Adolescents
2022Canada OKs Novavax's Covid Vaccine for Adolescents Aged 12-17
2022Novavax, Inc. Announces Nuvaxovid COVID-19 Vaccine Approval in Canada for Use as a Prim..
2022Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Ad..
2022Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference
2022Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference
2022TRADING UPDATES: XLMedia, Mobile Streams and Windar win deals
2022Novavax Says WHO Updates Emergency Use Listing for Its COVID-19 Vaccine
2022World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 ..
2022Novavax, Inc. Announces the World Health Organization Issue an Updated Emergency Use Li..
2022Novavax - Termination of COVID-19 Vaccine Purchase Agreement with Gavi
2022GAVI Alliance Refutes Novavax's Claims Of Breaching COVID-19 Vaccine Purchase Deal
2022Gavi rejects Novavax's claim on COVID vaccine deal breach
2022Gavi says it is not in breach of Novavax vaccine deal
2022Novavax Ends COVID-19 Vaccine Purchase Agreement With the Gavi Alliance
2022Novavax Ends COVID-19 Vaccine Purchase Deal With GAVI Amid Material Breach
2022Novavax ends COVID vaccine sale agreement with Gavi
2022Novavax ends COVID vaccine sale agreement with Gavi
2022Novavax Inc : Termination of a Material Definitive Agreement (form 8-K)
Prochain événement sur NOVAVAX, INC.